antisense has arrived but the street still gives no respect to ISIS. All the negatives that have surrounded Kynarmo are still in the forefront with potential investors.
They need to get over it or miss out what I think will be some nice upward PPS movement
Over the next 2 years ISIS has several potential significant PPS drivers as its pipeline matures through P2B and some very $$$$big money deals are struck for these assets. EPS and within the biotech sector no need for cash thus dilution are still king with most investors.